Shopping Cart
- Remove All
- Your shopping cart is currently empty
BMSpep-57, a potent macrocyclic peptide inhibitor, competitively disrupts the PD-1/PD-L1 interaction, demonstrating a significant inhibitory concentration (IC50) of 7.68 nM. It exhibits binding affinity towards PD-L1 with dissociation constants (Kd) of 19 nM and 19.88 nM in MicroScale Thermophoresis (MST) and Surface Plasmon Resonance (SPR) assays, respectively. This compound enhances T cell functionality by promoting Interleukin-2 (IL-2) production within Peripheral Blood Mononuclear Cells (PBMCs).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,520 | Backorder |
Description | BMSpep-57, a potent macrocyclic peptide inhibitor, competitively disrupts the PD-1/PD-L1 interaction, demonstrating a significant inhibitory concentration (IC50) of 7.68 nM. It exhibits binding affinity towards PD-L1 with dissociation constants (Kd) of 19 nM and 19.88 nM in MicroScale Thermophoresis (MST) and Surface Plasmon Resonance (SPR) assays, respectively. This compound enhances T cell functionality by promoting Interleukin-2 (IL-2) production within Peripheral Blood Mononuclear Cells (PBMCs). |
Targets&IC50 | PD-1/PD-L1:7.68 nM (IC50) |
In vitro | In an ELISA competition assay, BMSpep-57 inhibits PD-1/PD-L1 binding by up to 98.1% at 300 nM, with a concentration-dependent inhibition and an IC50 of 7.68 nM [1]. BMSpep-57 induces high levels of IL-2 at 1 μM and 500 nM in SEB-stimulated peripheral blood mononuclear cells [1]. BMSpep-57 (0.2-10 μM; 24 hours) does not affect the viability of Jurkat, CHO, and HepG2 cells at the tested concentrations [1]. |
Molecular Weight | 1868.2 |
Formula | C89H126N24O19S |
Cas No. | 1629655-80-6 |
Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.